Role of Oxidized Regenerated Cellulose Gauze in Managing Intraoperative Bleeding During Myomectomy
Uterine fibroids are a common health condition affecting millions of women globally, often leading to symptoms such as heavy menstrual bleeding, pelvic pain, and infertility, which significantly diminish a woman’s quality of life [1]. For women who seek to preserve fertility or alleviate these distressing symptoms, myomectomy—the surgical removal of fibroids—is a preferred treatment. However, a critical challenge during myomectomy is the management of intraoperative bleeding, which can be life-threatening if uncontrolled [2]. Excessive blood loss can prolong the surgery, complicate recovery, increase the risk of infection, and potentially require blood transfusions. As a result, addressing intraoperative bleeding efficiently is essential for improving surgical outcomes and reducing postoperative complications. This blog explores how advanced hemostatic agents, particularly oxidized regenerated cellulose gauze (ORCG), are transforming the way surgeons manage bleeding during myomecto